# MAPK8IP2

## Overview
MAPK8IP2, also known as JIP2, is a gene that encodes the mitogen-activated protein kinase 8 interacting protein 2, a scaffold protein integral to the regulation of the MAP kinase signaling pathways, particularly the c-Jun N-terminal kinase (JNK) pathway. The protein is characterized by its structural domains, including the SH3, PTB, and JNK-binding domains, which facilitate its role in organizing and mediating interactions among various signaling molecules (Zeng2022MAPK8IP2; Zhenhao2023A). As a scaffold protein, JIP2 is crucial for the assembly of signaling complexes that influence neurodevelopmental processes, cell migration, differentiation, and apoptosis (Zeng2022MAPK8IP2; Roessler2018JIP2). Its involvement in these pathways underscores its significance in both normal cellular functions and pathological conditions, such as cancer and neurodevelopmental disorders, making it a potential target for therapeutic interventions (Zeng2022MAPK8IP2; Roessler2018JIP2).

## Structure
MAPK8IP2, also known as JIP2, is a scaffold protein involved in the JNK and P38 MAPK signaling pathways. The molecular structure of MAPK8IP2 includes several key domains that are crucial for its function. It contains an SH3 domain, a PTB domain, and a JNK-binding domain, which are similar to those found in JIP1 (Zeng2022MAPK8IP2; Zhenhao2023A). These domains facilitate interactions with other proteins and are essential for its role in signaling pathways.

The SH3 domain is typically involved in protein-protein interactions, while the PTB domain is known for binding phosphotyrosine-containing motifs. The JNK-binding domain allows MAPK8IP2 to interact directly with JNK proteins, playing a significant role in the regulation of the MAPK signaling pathway. This structural configuration enables MAPK8IP2 to act as a scaffold, organizing and facilitating the interactions of various signaling molecules.

While specific details on the primary, secondary, tertiary, and quaternary structures of MAPK8IP2 are not provided in the context, the presence of these domains suggests a complex three-dimensional structure that supports its function in cellular signaling processes. The protein's structure is integral to its role in both cancer progression and neurodevelopmental processes.

## Function
MAPK8IP2, also known as JIP2, is a scaffold protein that plays a significant role in the regulation of the MAP kinase pathways, particularly the JNK signaling pathway. In healthy human cells, JIP2 is involved in neurodevelopmental processes by facilitating the assembly of signaling complexes that are crucial for neuronal maturation and function. It interacts with JNK proteins, which are essential for proper neuron differentiation and maturation (Roessler2018JIP2).

JIP2 is primarily active in the cytoplasm, where it regulates the localization and timing of signal activation through interactions with various kinases. This regulation is vital for processes such as cell migration, differentiation, and apoptosis (Zeng2022MAPK8IP2). The protein's role in the semaphorin signaling pathway, involving neuropilin receptor 1 (NRP1), highlights its importance in activating JNK proteins, which can be pharmacologically modulated to rescue JNK expression in neurons (Roessler2018JIP2).

JIP2's involvement in these pathways underscores its critical function in maintaining normal cellular processes and its potential as a therapeutic target for neurodevelopmental disorders (Roessler2018JIP2).

## Clinical Significance
MAPK8IP2 has been implicated in several diseases due to its altered expression or interactions. In prostate cancer (PCa), MAPK8IP2 is significantly overexpressed, correlating with poor prognosis and adverse clinicopathological factors. Its high expression is associated with shorter progression-free intervals and overall survival, making it a potential prognostic biomarker and therapeutic target in PCa (Zeng2022MAPK8IP2). Genetic alterations in MAPK8IP2, although infrequent, are linked to poorer progression-free survival in PCa patients (Zeng2022MAPK8IP2).

In glioblastoma (GBM), MAPK8IP2 is downregulated, which is associated with reduced synaptic transmission and neuronal differentiation. Its expression levels vary across GBM subtypes, suggesting its potential as a prognostic biomarker for this type of brain cancer (Li2022Gene).

MAPK8IP2 is also involved in neurodevelopmental disorders. Knockout mice studies indicate that loss of MAPK8IP2 leads to autistic-like behaviors and impaired neuronal maturation, suggesting a link to autism spectrum disorder (ASD) (Ricciardello2021Genotype–phenotype).

In ovarian carcinoma, MAPK8IP2 is part of gene sets associated with the Apelin signaling pathway, which may influence cancer progression and serve as a therapeutic target (Wu2021A).

## Interactions
MAPK8IP2, also known as JIP2, is a scaffold protein that plays a significant role in the mitogen-activated protein kinase (MAPK) signaling pathways, particularly the c-Jun N-terminal kinase (JNK) pathway. It interacts with various components of the MAPK signaling cascade, including mixed-lineage kinase 3 (MLK3), MAP kinase kinase 7 (MKK7), and JNK itself. These interactions are facilitated by specific domains within JIP2, such as the JNK binding domain (JBD) in the NH2-terminal region and the SH3 and PTB domains in the COOH-terminal region (Yasuda1999The).

JIP2 forms both homo- and hetero-oligomeric complexes with other JIP proteins, such as JIP1, enhancing the activation of JNK by MLK protein kinases. This scaffolding function is crucial for the selective mediation of signaling by the MLK3-MKK7-JNK pathway (Yasuda1999The). JIP2 also interacts with Rac GEFs like Tiam1 and Ras-GRF1, which activate Rac GTPase, linking it to upstream regulatory proteins in the p38 MAPK signaling pathway (Long2007Dosedependent). These interactions highlight JIP2's role in organizing and facilitating signal transduction within the MAPK pathways.


## References


[1. (Zhenhao2023A) Zeng Zhenhao, Chen Ru, Cheng Xiaofeng, Yang Heng, and Wang Gongxian. A novel circular rna, circmaml3, promotes tumor progression of prostate cancer by regulating mir-665/mapk8ip2 axis. Cell Death Discovery, December 2023. URL: http://dx.doi.org/10.1038/s41420-023-01750-1, doi:10.1038/s41420-023-01750-1. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-023-01750-1)

[2. (Wu2021A) Jingli Wu, Kai Zhu, Gaoshi Li, Jinyan Wang, and Qirong Cai. A model and algorithm for identifying driver pathways based on weighted non-binary mutation matrix. Applied Intelligence, 52(1):127–140, April 2021. URL: http://dx.doi.org/10.1007/s10489-021-02330-5, doi:10.1007/s10489-021-02330-5. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10489-021-02330-5)

[3. (Roessler2018JIP2) Reinhard Roessler, Johanna Goldmann, Chikdu Shivalila, and Rudolf Jaenisch. Jip2 haploinsufficiency contributes to neurodevelopmental abnormalities in human pluripotent stem cell–derived neural progenitors and cortical neurons. Life Science Alliance, 1(4):e201800094, June 2018. URL: http://dx.doi.org/10.26508/lsa.201800094, doi:10.26508/lsa.201800094. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.26508/lsa.201800094)

[4. (Zeng2022MAPK8IP2) Zhenhao Zeng, Wenrui He, Yi Jiang, Hao Jiang, Xiaofeng Cheng, Wen Deng, Xiaochen Zhou, Cheng Zhang, and Gongxian Wang. Mapk8ip2 is a potential prognostic biomarker and promote tumor progression in prostate cancer. BMC Cancer, November 2022. URL: http://dx.doi.org/10.1186/s12885-022-10259-2, doi:10.1186/s12885-022-10259-2. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-022-10259-2)

[5. (Li2022Gene) Qiang Li, S. Aishwarya, Ji-Ping Li, Dong-Xiao Pan, and Jia-Pei Shi. Gene expression profiling of glioblastoma to recognize potential biomarker candidates. Frontiers in Genetics, April 2022. URL: http://dx.doi.org/10.3389/fgene.2022.832742, doi:10.3389/fgene.2022.832742. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.832742)

[6. (Yasuda1999The) Jun Yasuda, Alan J. Whitmarsh, Julie Cavanagh, Manoj Sharma, and Roger J. Davis. The jip group of mitogen-activated protein kinase scaffold proteins. Molecular and Cellular Biology, 19(10):7245–7254, October 1999. URL: http://dx.doi.org/10.1128/mcb.19.10.7245, doi:10.1128/mcb.19.10.7245. This article has 360 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.19.10.7245)

[7. (Ricciardello2021Genotype–phenotype) Arianna Ricciardello, Pasquale Tomaiuolo, and Antonio M. Persico. Genotype–phenotype correlation in <scp>phelan‐mcdermid</scp> syndrome: a comprehensive review of chromosome 22q13 deleted genes. American Journal of Medical Genetics Part A, 185(7):2211–2233, May 2021. URL: http://dx.doi.org/10.1002/ajmg.a.62222, doi:10.1002/ajmg.a.62222. This article has 33 citations.](https://doi.org/10.1002/ajmg.a.62222)

[8. (Long2007Dosedependent) Xian-Hui Long, Zeng-Qiang Zhao, Xing-Peng He, Hui-Ping Wang, Qin-Zhi Xu, Jing An, Bei Bai, Jian-Li Sui, and Ping-Kun Zhou. Dose-dependent expression changes of early response genes to ionizing radiation in human lymphoblastoid cells. International Journal of Molecular Medicine, April 2007. URL: http://dx.doi.org/10.3892/ijmm.19.4.607, doi:10.3892/ijmm.19.4.607. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijmm.19.4.607)